Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping

  • Cardiac
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the incidence of late-gadolinium-enhancement (LGE) in mitral valve prolapse (MVP) (in the absence of other heart/valvular diseases), and its association with the degree of mitral regurgitation (MR) and/or with complex ventricular arrhythmia (ComVA), and to analyse the role of T1 mapping in the evaluation of MVP patients.

Methods

We included all consecutive patients with MVP who underwent during 2015–2016 a comprehensive cardiac magnetic resonance (CMR) examination at 1.5 T. We evaluated the association of LGE with the MR fraction and the presence of ComVA. We compared myocardial T1-native and post-contrast times and extracellular volume (ECV)-values between MVP patients, both with and without LGE, and the control group.

Results

Thirty-four patients with MVP were selected (56 ± 14 years old, 59% male). All patients had MR; LGE and ComVA were present in 15 (44%) and 11 (34%) patients, respectively. Significant associations of LGE with both MR severity and ComVA were not found (p=0.72 and 0.79, respectively). T1 mapping confirmed the presence of LGE in all cases. In one patient a thin signal alteration resulted in more evident T1 mapping than LGE. Patients with MVP had higher native T1-values, lower post-contrast T1-values and increased ECV-values compared with controls (p=0.01, 0.01 and 0.00, respectively).

Conclusion

Focal fibrosis with LGE was found in about half the MVP patients and it was independent of the degree of the valve dysfunction and the presence of ComVA. T1 mapping allows diffuse myocardial wall alterations to be identified, but no significant associations between the MR severity and ComVA and T1/ECV values were found.

Key Points

• MVP is a common valvulopathy affecting 2–3% of the general population.

• MVP has been associated with an increased risk of arrhythmic complications and sudden cardiac death.

• CMR is a non-invasive imaging method that provides a precise and more accurate assessment of patients with MVP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

Abbreviations

2C:

2-chamber

3C:

3-chamber

4C:

4-chamber

AHA:

American Heart Association

CMR:

Cardiac magnetic resonance

ComVA:

Complex ventricular arrhythmias

ECV:

Extracellular volume

LGE:

Late gadolinium enhancement

LV:

Left ventricular

MOLLI:

Modified Look-Locker inversion

MR:

Mitral regurgitation

MVP:

Mitral valve prolapse

PACS:

Picture Archiving and Communication System

PSIR:

Phase-sensitive inversion recovery

RV:

Right ventricular

SA:

Short-axis

SCD:

Sudden cardiac death

SSFP:

Steady-state free processing

SV:

Stroke volume

References

  1. Freed LA, Levy D, Levine RA et al (1999) Prevalence and Clinical Outcome of Mitral-Valve Prolapse. N Engl J Med 341:1–7

    Article  CAS  PubMed  Google Scholar 

  2. Basso C, Perazzolo Marra M, Rizzo S et al (2015) Arrhythmic mitral valve prolapse and sudden cardiac death clinical perspective. Circulation 132(7):556–566

    Article  PubMed  Google Scholar 

  3. Han Y, Peters DC, Salton CJ et al (2008) Cardiovascular Magnetic Resonance Characterization of Mitral Valve Prolapse. JACC Cardiovasc Imaging 1:294–303

    Article  PubMed  Google Scholar 

  4. Nishimura RA, Carabello B (2016) Operationalizing the 2014 ACC/AHA guidelines for valvular heart disease. J Am Coll Cardiol 67:2289–2294

    Article  PubMed  Google Scholar 

  5. Moore M, Chen J (2016) The direct health-care burden of valvular heart disease: evidence from US national survey data. Clinicoecon Outcomes Res 8:613–627

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hahn RT (2016) Transcathether valve replacement and valve repair: review of procedures and intraprocedural echocardiographic imaging. Circ Res 119:341–356

    Article  CAS  PubMed  Google Scholar 

  7. Hamlin SA, Henry TS, Little BP et al (2014) Mapping the future of cardiac MR imaging: case-based review of T1 and T2 mapping techniques. Radiographics 34(6):1594–1611

    Article  PubMed  Google Scholar 

  8. Mewton N, Liu CY, Croisille P et al (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903

    Article  PubMed  Google Scholar 

  9. Weidemann F, Herrmann S, Störk S et al (2009) Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120:577–584

    Article  CAS  PubMed  Google Scholar 

  10. Jellis C, Martin J, Narula J et al (2010) Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56:89–97

    Article  CAS  PubMed  Google Scholar 

  11. Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383

    Article  PubMed  Google Scholar 

  12. Uretsky S, Gillam L, Lang R et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: A prospective multicenter trial. J Am Coll Cardiol 65:1078–1088

    Article  PubMed  Google Scholar 

  13. Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 148:e1–e132

    Article  PubMed  Google Scholar 

  14. Vohra J, Sathe S, Warren R et al (1993) Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation. Pacing Clin Electrophysiol 16:387–393

    Article  CAS  PubMed  Google Scholar 

  15. Niu Z, Chan V, Mesana T, Ruel M (2016) The evolution of mitral valve prolapse: Insights from the Framingham Heart Study. J Thorac Dis 8:E827–E828

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bui AH, Roujol S, Foppa M et al (2017) Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart 103(3):204–209

    Article  PubMed  Google Scholar 

  17. Narayanan K, Uy-evanado A, Teodorescu C et al (2016) Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm 13:498–503

    Article  PubMed  Google Scholar 

  18. Lown B, Wolf M (1971) Approaches to sudden death from coronary heart disease. Circulation 44:130–142

    Article  CAS  PubMed  Google Scholar 

  19. Kon MWS, Myerson SG, Moat NE, Pennell DJ (2004) Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 13:600–607

    PubMed  Google Scholar 

  20. Gelfand EV, Hughes S, Hauser TH et al (2006) Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 8(3):503–507

    Article  PubMed  Google Scholar 

  21. Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18(1):539–542

  22. Treibel TA, Fontana M, Maestrini V et al (2016) Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging 9:54–63

    Article  PubMed  Google Scholar 

  23. Ugander M, Oki AJ, Hsu LY et al (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33:1268–1278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Van De Heyning CM, Magne J, Piérard LA et al (2014) Late gadolinium enhancement CMR in primary mitral regurgitation. Eur J Clin Invest 44(9):840–847

    Article  Google Scholar 

  25. Marra MP, Basso C, De Lazzari M et al (2016) Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging 9:1–10

    Article  Google Scholar 

  26. Sheppard MN, Steriotis AK, Sharma S (2016) Letter by Sheppard at al regarding article "Arrhythmic mitral valve prolapse and sudden cardiac death". Circulation 133:e458

    Article  PubMed  Google Scholar 

  27. Spartalis M, Tzatzaki E, Spartalis E et al (2017) Mitral valve prolapse: an underestimated cause of sudden cardiac death - a current review of the literature. J Thorac Dis 9:5390–5398

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fujita N, Chazouilleres AF, Hartiala JJ et al (1994) Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 23:951–958

  29. Kizilbash AM, Hundley WG, Willett DL et al (1998) Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. Am J Cardiol 81:792–795

    Article  CAS  PubMed  Google Scholar 

  30. Lopez-Mattei JC, Shah DJ (2013) The role of cardiac magnetic resonance in valvular heart disease. Methodist Debakey Cardiovasc J 9:142–148

    Article  PubMed  PubMed Central  Google Scholar 

  31. Edwards NC, Moody WE, Yuan M et al (2014) Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging 7(6):946–953

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Pradella.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Prof. Stefano Colagrande.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• Observational

• Performed at one institution

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pradella, S., Grazzini, G., Brandani, M. et al. Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping. Eur Radiol 29, 1546–1554 (2019). https://doi.org/10.1007/s00330-018-5634-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-018-5634-5

Keywords